BR0012386A - (oxatiepino-[6,5-b]-dihidropiridinas e composições e processos relacionados - Google Patents

(oxatiepino-[6,5-b]-dihidropiridinas e composições e processos relacionados

Info

Publication number
BR0012386A
BR0012386A BR0012386-2A BR0012386A BR0012386A BR 0012386 A BR0012386 A BR 0012386A BR 0012386 A BR0012386 A BR 0012386A BR 0012386 A BR0012386 A BR 0012386A
Authority
BR
Brazil
Prior art keywords
dihydropyridines
processes
disorders
oxatiepino
related compositions
Prior art date
Application number
BR0012386-2A
Other languages
English (en)
Inventor
John H Dodd
James R Henry
Kenneth C Rupert
James L Bullington
Daniel A Hall
Original Assignee
Ortho Mcneil Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharmaceutical Co filed Critical Ortho Mcneil Pharmaceutical Co
Publication of BR0012386A publication Critical patent/BR0012386A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"OXATIEPINO-[ 6,5-b ]-DIHIDROPIRIDINAS E COMPOSIçõES E PROCESSOS RELACIONADOS". Esta invenção proporciona novas oxatiepino-[ 6,5-b ]-dihidropiridinas. Esses compostos são úteis como antagonistas de canais de cálcio com atividade cardiovascular, antiasmática e antibroncoconstrição. Assim, essa invenção também proporciona composições farmacêuticas, assim como processos, para prevenção e tratamento de distúrbios tais como hipersensibilidade, alergia, asma, broncoespasmo, dismenorréia, espasmo esofágico, glaucoma, parto prematuro, distúrbios do trato urinário, distúrbios da motilidade gastrointestinal e distúrbios cardiovasculares.
BR0012386-2A 1999-07-12 2000-06-23 (oxatiepino-[6,5-b]-dihidropiridinas e composições e processos relacionados BR0012386A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14335499P 1999-07-12 1999-07-12
PCT/US2000/017310 WO2001004124A1 (en) 1999-07-12 2000-06-23 OXATHIEPINO[6,5-b]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS

Publications (1)

Publication Number Publication Date
BR0012386A true BR0012386A (pt) 2002-05-28

Family

ID=22503704

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0012386-2A BR0012386A (pt) 1999-07-12 2000-06-23 (oxatiepino-[6,5-b]-dihidropiridinas e composições e processos relacionados

Country Status (22)

Country Link
US (1) US6476022B1 (pt)
EP (1) EP1200446B1 (pt)
JP (1) JP2003504373A (pt)
KR (1) KR20020012308A (pt)
CN (1) CN1188416C (pt)
AR (1) AR030396A1 (pt)
AT (1) ATE302206T1 (pt)
AU (1) AU779498B2 (pt)
BR (1) BR0012386A (pt)
CA (1) CA2379199A1 (pt)
CZ (1) CZ2002126A3 (pt)
DE (1) DE60022056T2 (pt)
DK (1) DK1200446T3 (pt)
ES (1) ES2246248T3 (pt)
HK (1) HK1045506B (pt)
HU (1) HUP0202265A3 (pt)
IL (2) IL147540A0 (pt)
MX (1) MXPA02000436A (pt)
PL (1) PL352760A1 (pt)
RU (1) RU2257388C2 (pt)
TW (1) TWI256394B (pt)
WO (1) WO2001004124A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100870527B1 (ko) * 2003-03-28 2008-11-26 닛산 가가쿠 고교 가부시키 가이샤 Ｔ형 칼슘 채널 저해제

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA429975A (en) 1945-09-11 F. D'alelio Gaetano Triazine derivative
US4285955A (en) 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
US4483985A (en) 1978-10-31 1984-11-20 Bayer Aktiengesellschaft Production of 1,4-dihydropyridinecarboxylic acids
NZ201395A (en) 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS58201764A (ja) 1982-05-17 1983-11-24 Maruko Seiyaku Kk ジヒドロピリジン誘導体
JPS6139760A (ja) 1984-07-31 1986-02-25 Toshiba Electric Equip Corp 集合住宅用インタ−ホン装置
JPS62253161A (ja) 1986-01-29 1987-11-04 Fuji Photo Film Co Ltd カラ−画像形成法
US4845225A (en) 1986-04-09 1989-07-04 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno [3,2-b] pyridines
US4777167A (en) * 1986-04-09 1988-10-11 Ortho Pharmaceutical Corporation Pharmaceutically useful substituted thiacycloalkeno [3,2-b]pyridines, compositions and method of use
US4879384A (en) 1988-06-15 1989-11-07 Ortho Pharmaceutical Corporation Preparation of thiocycloalkno [3,2-b] pyridines
US5075440A (en) * 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
DE19532320A1 (de) 1995-09-01 1997-03-06 Bayer Ag Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen
AU771033B2 (en) * 1999-06-14 2004-03-11 Ortho-Mcneil Pharmaceutical, Inc. Dithiepino(6,5-b)pyridines, and related compositions and methods

Also Published As

Publication number Publication date
US6476022B1 (en) 2002-11-05
CA2379199A1 (en) 2001-01-18
WO2001004124A1 (en) 2001-01-18
MXPA02000436A (es) 2002-10-11
KR20020012308A (ko) 2002-02-15
DE60022056D1 (de) 2005-09-22
AR030396A1 (es) 2003-08-20
IL147540A (en) 2006-12-10
EP1200446B1 (en) 2005-08-17
ATE302206T1 (de) 2005-09-15
EP1200446A1 (en) 2002-05-02
ES2246248T3 (es) 2006-02-16
RU2257388C2 (ru) 2005-07-27
HUP0202265A3 (en) 2004-12-28
DE60022056T2 (de) 2006-06-08
IL147540A0 (en) 2002-08-14
DK1200446T3 (da) 2005-10-24
CN1372563A (zh) 2002-10-02
HK1045506A1 (en) 2002-11-29
HUP0202265A2 (en) 2002-10-28
AU6605000A (en) 2001-01-30
PL352760A1 (en) 2003-09-08
TWI256394B (en) 2006-06-11
CZ2002126A3 (cs) 2003-04-16
AU779498B2 (en) 2005-01-27
HK1045506B (zh) 2006-02-03
JP2003504373A (ja) 2003-02-04
CN1188416C (zh) 2005-02-09

Similar Documents

Publication Publication Date Title
ATE380029T1 (de) Prodrugs von gaba-analoga, zusammensetzungen und ihre verwendungszwecke
BR9917527A (pt) Compostos como agonistas de delta opióide delta
BR0211905A (pt) Dialdeìdos de rapamicina
WO2007002884A3 (en) 4-fluoro-piperidine t-type calcium channel antagonists
ATE509004T1 (de) 3-alkylierte 5,5',6,6',7,7',8,8'-octahydro-2, 2'binaphthole und 3,3'-dialkylierte 5,5',6,6',7, 7',8,8'-octahydro-2,2'-binaphthole sowie herstellungsverfahren dafür
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
WO2006094187A3 (en) Phthalazine, aza- and diaza-phthalazine compounds and methods of use
WO2002064594A3 (en) 6-substituted pyrido-pyrimidines
WO2008045393A3 (en) Imidazo- and triazolo-pyridine compounds and methods of use therof
BR0007778A (pt) Peptidila cetonas heterocìclicas úteis como inibidores de triptase
BR0211450A (pt) Método terapêutico
WO2009038757A3 (en) Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
GB0111186D0 (en) Novel compounds
SG149045A1 (en) Novel fused pyrrolocarbazoles
SG149042A1 (en) Novel fused pyrrolocarbazoles
GB0322510D0 (en) Novel compounds
WO2003087062A3 (en) 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
EP1532131A4 (en) COMPOUNDS OF THE MOTILID TYPE
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
DK1196442T3 (da) VGF-polypeptider og fremgangsmåder til behandling af VGF-relaterede lidelser
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
BR0012386A (pt) (oxatiepino-[6,5-b]-dihidropiridinas e composições e processos relacionados
MY122510A (en) Benzo-fused dithiepino[6,5-b]pyridines, and related compositions and methods
BR0012215A (pt) Ditiepino[6,5-b]piridinas e composições e métodos relacionados
WO2002051855A3 (en) Motilide compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009.